Abe, K., and H. Kimura. The possible role of hydrogen sulfide as an endogenous neuromodulator. J. Neurosci. 16(3):1066–1071, 1996.
Ahmed, K. K., S. M. Geary, and A. K. Salem. Development and evaluation of biodegradable particles coloaded with antigen and the toll-like receptor agonist, pentaerythritol lipid A, as a cancer vaccine. J. Pharm. Sci. US 105(3):1173–1179, 2016.
Ahmed, K. K., S. M. Geary, and A. K. Salem. Surface engineering tumor cells with adjuvant-loaded particles for use as cancer vaccines. J. Control Release 248:1–9, 2017.
Aprioku, J. S. Pharmacology of free radicals and the impact of reactive oxygen species on the testis. J. Reprod. Infertil. 14(4):158–172, 2013.
Atluri, K., A. M. De Jesus, S. Chinnathambi, M. J. Brouillette, J. A. Martin, A. K. Salem, and E. A. Sander. Blebbistatin-loaded poly(d, l-lactide-co-glycolide) particles for treating arthrofibrosis. ACS Biomater. Sci. Eng. 2(7):1097–1107, 2016.
Bhatia, M. Hydrogen sulfide as a vasodilator. IUBMB Life 57(9):603–606, 2005.
Bos, E. M., R. Wang, P. M. Snijder, M. Boersema, J. Damman, M. Fu, J. Moser, J.-L. Hillebrands, R. J. Ploeg, G. Yang, H. G. D. Leuvenink, and H. van Goor. Cystathionine γ-lyase protects against renal ischemia/reperfusion by modulating oxidative stress. J. Am. Soc. Nephrol. 24(5):759–770, 2013.
Caliendo, G., G. Cirino, V. Santagada, and J. L. Wallace. Synthesis and biological effects of hydrogen sulfide (H2S): development of H2S-releasing drugs as pharmaceuticals. J. Med. Chem. 53(17):6275–6286, 2010.
Cheng, Y., S. Deng, P. Chen, and R. Ruan. Polylactic acid (PLA) synthesis and modifications: a review. Front. Chem. China 4(3):259–264, 2009.
Cui, F., Y. Li, S. Zhou, M. Jia, X. Yang, F. Yu, S. Ye, Z. Hou, and L. Xie. A comparative in vitro evaluation of self-assembled PTX-PLA and PTX-MPEG-PLA nanoparticles. Nanoscale Res. Lett. 8(1):301, 2013.
Do, A. V., S. M. Geary, D. Seol, P. Tobias, D. Carlsen, N. Leelakanok, J. A. Martin, and A. K. Salem. Combining ultrasound and intratumoral administration of doxorubicin-loaded microspheres to enhance tumor cell killing. Int. J. Pharma. 539(1–2):139–146, 2018.
Ebeid, K., X. Meng, K. W. Thiel, A. V. Do, S. M. Geary, A. S. Morris, E. L. Pham, A. Wongrakpanich, Y. S. Chhonker, D. J. Murry, K. K. Leslie, and A. K. Salem. Synthetically lethal nanoparticles for treatment of endometrial cancer. Nat. Nanotechnol. 13(1):72–81, 2018.
Elsawy, M. A., K.-H. Kim, J.-W. Park, and A. Deep. Hydrolytic degradation of polylactic acid (PLA) and its composites. Renew. Sustain. Energy Rev. 79:1346–1352, 2017.
Geary, S. M., Q. Hu, V. B. Joshi, N. B. Bowden, and A. K. Salem. Diaminosulfide based polymer microparticles as cancer vaccine delivery systems. J. Control Release 220(Pt B):682–690, 2015.
Gemici, B., W. Elsheikh, K. B. Feitosa, S. K. Costa, M. N. Muscara, and J. L. Wallace. H2S-releasing drugs: anti-inflammatory, cytoprotective and chemopreventative potential. Nitric Oxide 46:25–31, 2015.
Gemici, B., and J. L. Wallace. Anti-inflammatory and cytoprotective properties of hydrogen sulfide. Methods Enzymol. 555:169–193, 2015.
Gerő, D., R. Torregrossa, A. Perry, A. Waters, S. Le-Trionnaire, J. L. Whatmore, M. Wood, and M. Whiteman. The novel mitochondria-targeted hydrogen sulfide (H2S) donors AP123 and AP39 protect against hyperglycemic injury in microvascular endothelial cells in vitro. Pharmacol. Res. 113:186–198, 2016.
Goudarzi, F., A. Asadi, M. Afsharpour, and R. H. Jamadi. In vitro characterization and evaluation of the cytotoxicity effects of nisin and nisin-loaded PLA-PEG-PLA nanoparticles on gastrointestinal (AGS and KYSE-30), hepatic (HepG2) and blood (K562) cancer cell lines. AAPS PharmSciTech 19(4):1554–1566, 2018.
Guidotti, T. L. Hydrogen sulfide: advances in understanding human toxicity. Int. J. Toxicol. 29(6):569–581, 2010.
Guo, W., Z. Y. Cheng, and Y. Z. Zhu. Hydrogen sulfide and translational medicine. Acta Pharmacol. Sin. 34(10):1284–1291, 2013.
Hunter, P. The inflammation theory of disease: the growing realization that chronic inflammation is crucial in many diseases opens new avenues for treatment. EMBO Rep. 13(11):968–970, 2012.
Ichikawa, Y., M. Ghanefar, M. Bayeva, R. Wu, A. Khechaduri, S. V. N. Prasad, R. K. Mutharasan, T. J. Naik, and H. Ardehali. Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation. J. Clin. Investig. 124(2):617–630, 2014.
Jeney, V., E. Komódi, E. Nagy, A. Zarjou, G. M. Vercellotti, J. W. Eaton, G. Balla, and J. Balla. Supression of hemin-mediated oxidation of low-density lipoprotein and subsequent endothelial reactions by hydrogen sulfide (H(2)S). Free Radic. Biol. Med. 46(5):616–623, 2009.
Jiang, J., A. Chan, S. Ali, A. Saha, K. J. Haushalter, W.-L. M. Lam, M. Glasheen, J. Parker, M. Brenner, S. B. Mahon, H. H. Patel, R. Ambasudhan, S. A. Lipton, R. B. Pilz, and G. R. Boss. Hydrogen sulfide—mechanisms of toxicity and development of an antidote. Sci. Rep. 6:20831, 2016.
Joshi, V. B., A. Adamcakova-Dodd, X. Jing, A. Wongrakpanich, K. N. Gibson-Corley, P. S. Thorne, and A. K. Salem. Development of a poly (lactic-co-glycolic acid) particle vaccine to protect against house dust mite induced allergy. AAPS J. 16(5):975–985, 2014.
Joshi, V. B., S. M. Geary, and A. K. Salem. Biodegradable particles as vaccine delivery systems: size matters. AAPS J. 15(1):85–94, 2013.
Kamat, P. K., A. Kalani, and N. Tyagi. Role of hydrogen sulfide in brain synaptic remodeling. Methods Enzymol. 555:207–229, 2015.
Kartha, R. V., J. Zhou, L. B. Hovde, B. W. Cheung, and H. Schroder. Enhanced detection of hydrogen sulfide generated in cell culture using an agar trap method. Anal. Biochem. 423(1):102–108, 2012.
Kim, N., D. H. Jiang, A. M. Jacobi, K. A. Lennox, S. D. Rose, M. A. Behlke, and A. K. Salem. Synthesis and characterization of mannosylated pegylated polyethylenimine as a carrier for siRNA. Int. J. Pharm. 427(1):123–133, 2012.
Kimura, Y., R. Dargusch, D. Schubert, and D. H. Kimura. Hydrogen sulfide protects HT22 neuronal cells from oxidative stress. Antioxid. Redox Signal. 8(3–4):661–670, 2006.
Kimura, Y., Y. Goto, and H. Kimura. Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria. Antioxid. Redox Signal. 12(1):1–13, 2010.
Kimura, H., N. Shibuya, and Y. Kimura. Hydrogen sulfide is a signaling molecule and a cytoprotectant. Antioxid. Redox Signal. 17(1):45–57, 2012.
Lemke, C. D., S. M. Geary, V. B. Joshi, and A. K. Salem. Antigen-coated poly alpha-hydroxy acid based microparticles for heterologous prime-boost adenovirus based vaccinations. Biomaterials 34(10):2524–2529, 2013.
Liu, R., G.-H. Ma, Y.-H. Wan, and Z.-G. Su. Influence of process parameters on the size distribution of PLA microcapsules prepared by combining membrane emulsification technique and double emulsion-solvent evaporation method. Colloids Surf. B 45(3):144–153, 2005.
Lloyd, D. Hydrogen sulfide: clandestine microbial messenger? Trends Microbiol. 14(10):456–462, 2006.
Lobo, V., A. Patil, A. Phatak, and N. Chandra. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacognosy reviews 4(8):118–126, 2010.
Long, T. R., A. Wongrakpanich, A.-V. Do, A. K. Salem, and N. B. Bowden. Long-term release of a thiobenzamide from a backbone functionalized poly(lactic acid). Polym. Chem. 6(40):7188–7195, 2015.
Lougiakis, N., A. Papapetropoulos, E. Gikas, S. Toumpas, P. Efentakis, R. Wedmann, A. Zoga, Z. Zhou, E. K. Iliodromitis, A.-L. Skaltsounis, M. R. Filipovic, N. Pouli, P. Marakos, and I. Andreadou. Synthesis and pharmacological evaluation of novel adenine-hydrogen sulfide slow release hybrids designed as multitarget cardioprotective agents. J. Med. Chem. 59(5):1776–1790, 2016.
Madhavan Nampoothiri, K., N. R. Nair, and R. P. John. An overview of the recent developments in polylactide (PLA) research. Bioresour. Technol. 101(22):8493–8501, 2010.
Marutani, E., S. Kosugi, K. Tokuda, A. Khatri, R. Nguyen, D. N. Atochin, K. Kida, K. Van Leyen, K. Arai, and F. Ichinose. A novel hydrogen sulfide-releasing N-methyl-d-aspartate receptor antagonist prevents ischemic neuronal death. J. Biol. Chem. 287(38):32124–32135, 2012.
Mundargi, R. C., V. R. Babu, V. Rangaswamy, P. Patel, and T. M. Aminabhavi. Nano/micro technologies for delivering macromolecular therapeutics using poly(d, l-lactide-co-glycolide) and its derivatives. J. Control. Release 125(3):193–209, 2008.
Niu, W. N., P. K. Yadav, J. Adamec, and R. Banerjee. S-glutathionylation enhances human cystathionine beta-synthase activity under oxidative stress conditions. Antioxid. Redox Signal. 22(5):350–361, 2015.
Olson, K. R. The therapeutic potential of hydrogen sulfide: separating hype from hope. Am. J. Physiol. Regul. Integr. Comp. Physiol. 301(2):R297–R312, 2011.
Salem, A. K., P. C. Searson, and K. W. Leong. Multifunctional nanorods for gene delivery. Nat. Mater. 2(10):668–671, 2003.
Stefanis, L., R. E. Burke, and L. A. Greene. Apoptosis in neurodegenerative disorders. Curr. Opin. Neurol. 10(4):299–305, 1997.
Stloukal, P., P. Kucharczyk, V. Sedlarik, P. Bazant, and M. Koutny. Low Molecular weight poly(lactic acid) microparticles for controlled release of the herbicide metazachlor: preparation, morphology, and release kinetics. J. Agric. Food Chem. 60(16):4111–4119, 2012.
Thannickal, V. J., and B. L. Fanburg. Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell. Mol. Physiol. 279(6):L1005-28, 2000.
Tsuji, H., and K. Ikarashi. In vitro hydrolysis of poly(l-lactide) crystalline residues as extended-chain crystallites: II. Effects Hydrolys. Temp. Biomacromol. 5(3):1021–1028, 2004.
Vara, D., and G. Pula. Reactive oxygen species: physiological roles in the regulation of vascular cells. Curr. Mol. Med. 14(9):1103–1125, 2014.
Wallace, J. L., and R. Wang. Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter. Nat. Rev. Drug Discov. 14(5):329–345, 2015.
Wang, R. Two’s company, three’s a crowd: can H2S be the third endogenous gaseous transmitter? FASEB J. 16(13):1792–1798, 2002.
Wei, H.-L., C.-Y. Zhang, H.-F. Jin, C.-S. Tang, and J.-B. Du. Hydrogen sulfide regulates lung tissue-oxidized glutathione and total antioxidant capacity in hypoxic pulmonary hypertensive rats. Acta Pharmacol. Sin. 29:670, 2008.
Wen, Y.-D., H. Wang, S.-H. Kho, S. Rinkiko, X. Sheng, H.-M. Shen, and Y.-Z. Zhu. Hydrogen sulfide protects HUVECs against hydrogen peroxide induced mitochondrial dysfunction and oxidative stress. PLoS ONE 8(2):e53147, 2013.
Wongrakpanich, A., A. S. Morris, S. M. Geary, M. L. A. Joiner, and A. K. Salem. Surface-modified particles loaded with CaMKII inhibitor protect cardiac cells against mitochondrial injury. Int. J. Pharm. 520(1–2):275–283, 2017.
Wongrakpanich, A., I. A. Mudunkotuwa, S. M. Geary, A. S. Morris, K. A. Mapuskar, D. R. Spitz, V. H. Grassian, and A. K. Salem. Size-dependent cytotoxicity of copper oxide nanoparticles in lung epithelial cells. Environ. Sci. 3(2):365–374, 2016.
Xie, Z.-Z., Y. Liu, and J.-S. Bian. Hydrogen sulfide and cellular redox homeostasis. Oxid. Med. Cell. Longev. 2016:6043038, 2016.
Xu, L., K. Crawford, and C. B. Gorman. Effects of temperature and pH on the degradation of poly(lactic acid) brushes. Macromolecules 44(12):4777–4782, 2011.
Yang, G., K. Zhao, Y. Ju, S. Mani, Q. Cao, S. Puukila, N. Khaper, L. Wu, and R. Wang. Hydrogen sulfide protects against cellular senescence via S-sulfhydration of Keap1 and activation of Nrf2. Antioxid. Redox Signal. 18(15):1906–1919, 2013.
Yokoyama, C., Y. Sueyoshi, M. Ema, Y. Mori, K. Takaishi, and H. Hisatomi. Induction of oxidative stress by anticancer drugs in the presence and absence of cells. Oncol. Lett. 14(5):6066–6070, 2017.
Zhang, M., Q. Xiong, J. Chen, Y. Wang, and Q. Zhang. A novel cyclodextrin-containing pH-responsive star polymer for nanostructure fabrication and drug delivery. Polym. Chem. 4(19):5086–5095, 2013.
Zhao, Y., T. D. Biggs, and M. Xian. Hydrogen sulfide (H2S) releasing agents: chemistry and biological applications. Chem. Commun. 50(80):11788–11805, 2014.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.4